Similar articles for PMID: 23785233

Year	Number of Results
1992	1
1993	2
1995	2
1997	1
1999	2
2000	2
2001	1
2002	2
2003	2
2004	2
2005	4
2006	4
2007	5
2008	1
2009	5
2010	4
2011	10
2012	4
2013	11
2014	9
2015	6
2016	12
2017	7
2018	9
2019	12
2020	9
2021	10
2022	27
2023	10
2024	0

1

Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine.

Fairley SJ, Singh SR, Yilma AN, Waffo AB, Subbarayan P, Dixit S, Taha MA, Cambridge CD, Dennis VA. Fairley SJ, et al. Int J Nanomedicine. 2013;8:2085-99. doi: 10.2147/IJN.S44155. Epub 2013 May 30. Int J Nanomedicine. 2013. PMID: 23785233 Free PMC article.

2

Biodegradable PLGA85/15 nanoparticles as a delivery vehicle for Chlamydia trachomatis recombinant MOMP-187 peptide.

Taha MA, Singh SR, Dennis VA. Taha MA, et al. Nanotechnology. 2012 Aug 17;23(32):325101. doi: 10.1088/0957-4484/23/32/325101. Epub 2012 Jul 23. Nanotechnology. 2012. PMID: 22824940

3

A nanovaccine formulation of Chlamydia recombinant MOMP encapsulated in PLGA 85:15 nanoparticles augments CD4⁺ effector (CD44^high CD62L^low) and memory (CD44^high CD62L^high) T-cells in immunized mice.

Sahu R, Dixit S, Verma R, Duncan SA, Coats MT, Giambartolomei GH, Singh SR, Dennis VA. Sahu R, et al. Nanomedicine. 2020 Oct;29:102257. doi: 10.1016/j.nano.2020.102257. Epub 2020 Jun 28. Nanomedicine. 2020. PMID: 32610072 Free PMC article.

4

Encapsulation of Recombinant MOMP in Extended-Releasing PLGA 85:15 Nanoparticles Confer Protective Immunity Against a Chlamydia muridarum Genital Challenge and Re-Challenge.

Sahu R, Dixit S, Verma R, Duncan SA, Smith L, Giambartolomei GH, Singh SR, Dennis VA. Sahu R, et al. Front Immunol. 2021 Apr 14;12:660932. doi: 10.3389/fimmu.2021.660932. eCollection 2021. Front Immunol. 2021. PMID: 33936096 Free PMC article.

5

Poly(lactic acid)-poly(ethylene glycol) nanoparticles provide sustained delivery of a Chlamydia trachomatis recombinant MOMP peptide and potentiate systemic adaptive immune responses in mice.

Dixit S, Singh SR, Yilma AN, Agee RD 2nd, Taha M, Dennis VA. Dixit S, et al. Nanomedicine. 2014 Aug;10(6):1311-21. doi: 10.1016/j.nano.2014.02.009. Epub 2014 Mar 4. Nanomedicine. 2014. PMID: 24602605 Free PMC article.

6

Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein.

Sun G, Pal S, Weiland J, Peterson EM, de la Maza LM. Sun G, et al. Vaccine. 2009 Aug 6;27(36):5020-5. doi: 10.1016/j.vaccine.2009.05.008. Epub 2009 May 27. Vaccine. 2009. PMID: 19446590 Free PMC article.

7

Protection against genital tract Chlamydia trachomatis infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen.

Hadad R, Marks E, Kalbina I, Schön K, Unemo M, Lycke N, Strid Å, Andersson S. Hadad R, et al. APMIS. 2016 Dec;124(12):1078-1086. doi: 10.1111/apm.12605. APMIS. 2016. PMID: 27859689

8

Phosphate substitution in an AlOOH - TLR4 adjuvant system (SPA08) modulates the immunogenicity of Serovar E MOMP from Chlamydia trachomatis.

Visan L, Sanchez V, Kania M, de Montfort A, de la Maza LM, Ausar SF. Visan L, et al. Hum Vaccin Immunother. 2016 Sep;12(9):2341-50. doi: 10.1080/21645515.2016.1168958. Epub 2016 Apr 22. Hum Vaccin Immunother. 2016. PMID: 27104338 Free PMC article.

9

The Chlamydia M278 Major Outer Membrane Peptide Encapsulated in the Poly(lactic acid)-Poly(ethylene glycol) Nanoparticulate Self-Adjuvanting Delivery System Protects Mice Against a Chlamydia muridarum Genital Tract Challenge by Stimulating Robust Systemic and Local Mucosal Immune Responses.

Verma R, Sahu R, Dixit S, Duncan SA, Giambartolomei GH, Singh SR, Dennis VA. Verma R, et al. Front Immunol. 2018 Oct 15;9:2369. doi: 10.3389/fimmu.2018.02369. eCollection 2018. Front Immunol. 2018. PMID: 30374357 Free PMC article.

10

A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors.

Cheng C, Jain P, Bettahi I, Pal S, Tifrea D, de la Maza LM. Cheng C, et al. Vaccine. 2011 Sep 2;29(38):6641-9. doi: 10.1016/j.vaccine.2011.06.105. Epub 2011 Jul 8. Vaccine. 2011. PMID: 21742006 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

162 results

Results by year